Navigation Links
Eamonn Hobbs Joins the Board of Directors at Cappella
Date:2/17/2010

GALWAY, Ireland, February 17, 2010 /PRNewswire/ -- Cappella (http://www.cappella-med.com/), Inc. (Cappella), a medical device company developing dynamic solutions for the treatment of coronary bifurcation disease, announced the addition of Mr. Eamonn Hobbs to the Board of Directors ( http://www.cappella-med.eu/index.php?option=com_content&view=article&id=181:bf-directors&catid=4). According to Mr. Wolfgang Oster, MD, PhD, Chairman of the Board and Managing Partner at PolyTechnos Venture-Partners GmbH, "Eamonn's wealth of expertise and solid track record of success in our medical device field makes him a formidable source of wisdom and judgement for the road ahead of Cappella. The company's commercial programs and global market expansion will greatly benefit from Mr Hobbs' insights."

Mr. Eamonn Hobbs, President, CEO, & Director of Delcath Systems, Inc. is an entrepreneurial senior executive with over 25 years of medical device experience and demonstrated success in profitable business creation, general management, sales and marketing and product development. When asked to comment on his recent appointment, Mr. Hobbs stated, "I am delighted to join Cappella's Board of Directors and support the cause of this company which is all about addressing a substantial unmet medical need. Whereas long under-diagnosed and under-served, bifurcational lesions have now attracted the much deserved attention of the medical community and I am convinced that Cappella has put the best team on the field to tackle the challenge. I am thrilled to work with Dr. Art Rosenthal and our Board of Directors to deliver this technology to patients in need."

About Cappella, Inc.

Cappella, Inc. is a medical device company, developing novel solutions for the treatment of complex Coronary Artery Disease (CAD) and specifically bifurcation vascular disease. Cappella's initial product, the Sideguard(R) (http://www.cappella-med.eu/index.php?option=com_content&view=article&id=1&Itronary Sidebranch Stent & Delivery System offers interventional cardiologists a straightforward, effective solution that focuses on treating the sidebranch of diseased coronary arteries first, rather than the main vessel. More importantly, it allows the preferred stent of choice for the main vessel. An optimal stent design specific to the anatomy of the sidebranch, combined with the qualities of Nitinol now provide a dynamic solution for treating sidebranch disease. Cappella Medical Devices Ltd., Galway, Ireland is the R&D and manufacturing subsidiary of Cappella, Inc. For more information, see: http://www.cappella-med.com.

(Due to the length of some of the URLs in this release, it may be necessary to copy and paste the hyperlinks into your Internet browser's URL address field. Remove the space if one exists.)

Links: Cappella : http://www.cappella-med.com/

SOURCE Cappella Inc.


'/>"/>
SOURCE Cappella Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Former Air Force Surgeon General Joins Integrated Medical Systems Advisory Board
2. Anthera Pharmaceuticals Announces Agreement With the FDA on a SPA for Planned Phase 3 Varespladib A-002 Study; Daniel K. Spiegelman Joins Board of Directors
3. Steven Leventer Joins PharmaNet Development Group as Vice President, Clinical Research Neuroscience
4. New Life Agency, Inc. Joins Forces With The Diamond Institute and Walgreens Specialty Pharmacy to Introduce the Nations First In Vitro Fertilization Insurance Program
5. CooperVision Adds Global Professional Relations Role; Richard Clompus Joins Company as Vice President
6. Professor Riccardo Lencioni Joins Delcath Systems Scientific Advisory Board
7. Royalty Pharma Announces that Alexander von Perfall Joins Management Team
8. Howard Goldstein Joins Microchip Biotechnologies, Inc. as Executive Vice President
9. Scott Glenn Joins Exagen Diagnostics as Chairman and CEO
10. PFC Pharma Joins DATATRAKs CRO Connect Program
11. William Cork Joins Fenwal as Chief Technology Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2017)... , June 19, 2017  Researchers from DRUGSCAN ® ... they will host a live, complimentary webinar titled, "Untangling ... benchtop to the real world" on Wednesday June 28, ... This webinar will feature interviews with recreational ... into the manipulation techniques abusers use to prepare opioid ...
(Date:6/14/2017)... , June 14, 2017  ivWatch LLC, a ... effectiveness of intravenous (IV) therapy, is pleased to announce ... category of Nonsurgical Hospital Supplies and Equipment at the ... program for the medtech industry. The award was presented ... Jacob K. Javits Center in New York ...
(Date:6/13/2017)... , June 13, 2017 Zimmer Biomet Holdings, Inc. ... today announced that the U.S. Food and Drug Administration (FDA) ... 3, 2015 relating to its Zhejiang, China ... "The successful clearance of the Warning Letter ... manufacturing facility is a measure of the progress we have ...
Breaking Medicine Technology:
(Date:6/23/2017)... ... June 23, 2017 , ... The Rhode Island Quality ... Management Alerts and Dashboards, an innovative new service enabling healthcare providers to proactively ... Management Alerts and Dashboards provide near real-time data about patients admitted to and/or ...
(Date:6/23/2017)... ... ... By scoring 100% for fiscal management and accountability, the Arthritis National Research ... Charity Navigator, validating ANRF's work as a top charity in America. , This achievement ... earns ANRF a spot on their “ 10 Charities Worth Watching ” list as ...
(Date:6/23/2017)... ... ... Studies show evidence that carotenoids and antioxidants derived either from the diet or from ... how often do ophthalmologists and optometrists in Sweden recommend the use of nutritional supplements, ... symptoms of AMD? A study published recently in Dove Medical Press journal, ...
(Date:6/23/2017)... ... June 23, 2017 , ... Dr. Ran Y. ... has recently begun offering three new minimally invasive procedures to patients who want ... reducing downtime, Dr. Rubinstein is excited to bring microneedling, microneedling facials, and platelet ...
(Date:6/23/2017)... ... 2017 , ... Everybody has their own personal preference when it comes to ... some people don't like it at all. FindaTopDoc took a look at what makes ... can give readers a taste of their deepest, darkest fantasies and has the ability ...
Breaking Medicine News(10 mins):